INSULET CORPORATION Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2024-08-09: Form 10-Q; Exhibit 10.4; Description Amendment No. 4, dated as of June 27, 2024, to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care Inc. dated as of September 13, 2021..
- 2024-08-09: Form 10-Q; Exhibit 10.3; Description Amendment No. 3, dated as of March 20, 2024, to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care Inc. dated as of September 13, 2021..
- 2024-08-05: Form 8-K; Exhibit 10.1; Description Sixth Amendment to Credit Agreement, dated August 2, 2024, among Insulet Corporation, Insulet MA Securities Corporation, Morgan Stanley Senior Funding, Inc., as administrative agent, and the other lenders party thereto..
- 2024-05-20: Form 8-K; Exhibit 10.1; Description Addendum, dated as of May 15, 2024, to the Purchase Agreement by and between Insulet Corporation and NXP USA, Inc., dated October 12, 2017..
| Filed | Form | Exhibit | Description |
|---|
| 2024-08-09 | 10-Q | 10.4 | Amendment No. 4, dated as of June 27, 2024, to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care Inc. dated as of September 13, 2021. |
|---|
| 2024-08-09 | 10-Q | 10.3 | Amendment No. 3, dated as of March 20, 2024, to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care Inc. dated as of September 13, 2021. |
|---|
| 2024-08-05 | 8-K | 10.1 | Sixth Amendment to Credit Agreement, dated August 2, 2024, among Insulet Corporation, Insulet MA Securities Corporation, Morgan Stanley Senior Funding, Inc., as administrative agent, and the other lenders party thereto. |
|---|
| 2024-05-20 | 8-K | 10.1 | Addendum, dated as of May 15, 2024, to the Purchase Agreement by and between Insulet Corporation and NXP USA, Inc., dated October 12, 2017. |
|---|
| 2024-05-10 | 10-Q | 10.1 | Offer Letter between Ana Maria Chadwick and Insulet Corporation dated March 4, 2024 |
|---|
| 2024-03-01 | 8-K | 10.3 | Form of Performance Stock Unit Agreement |
|---|
| 2024-03-01 | 8-K | 10.2 | Form of Restricted Stock Unit Agreement |
|---|
| 2024-03-01 | 8-K | 10.1 | Form of Non-Qualified Stock Option Agreement |
|---|
| 2024-02-23 | 10-K | 10.64 | Amendment, dated November 30, 2019, to the Purchase Agreement dated October 12, 2017 by and between Insulet Corporation and NXP USA, Inc. |
|---|
| 2024-02-23 | 10-K | 10.59 | Purchase Agreement by and between Insulet Corporation and NXP USA, Inc., dated October 12, 2017 |
|---|
| 2024-02-23 | 10-K | 10.58 | Amendment No. 2 to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care, Inc., dated June 6, 2022 |
|---|
| 2024-02-23 | 10-K | 10.57 | Amendment No. 1 to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care, Inc., dated January 5, 2022 |
|---|
| 2024-02-23 | 10-K | 10.56 | Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care, Inc., dated September 13, 2021 |
|---|
| 2024-02-23 | 10-K | 10.33 | Temporary Acting Up Agreement between Lauren Budden and Insulet Corporation, dated October 30, 2023. |
|---|
| 2024-01-25 | 8-K | 10.1 | Fifth Amendment to Credit Agreement, dated January 24, 2024, among Insulet Corporation, Insulet MA Securities Corporation, Morgan Stanley Senior Funding, Inc., as administrative agent, and the other lenders party thereto. |
|---|